Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.0801 $0.360 Thursday, 9th May 2024 JAGX stock ended at $0.310. This is 15.74% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 31.45% from a day low at $0.246 to a day high of $0.323.
90 days $0.0519 $0.360
52 weeks $0.0519 $1.22

Historical Jaguar Health, Inc. prices

Date Open High Low Close Volume
Apr 05, 2023 $0.630 $0.630 $0.557 $0.570 1 389 436
Apr 04, 2023 $0.590 $0.670 $0.586 $0.612 1 914 318
Apr 03, 2023 $0.639 $0.639 $0.567 $0.585 1 431 080
Mar 31, 2023 $0.690 $0.710 $0.619 $0.628 2 514 535
Mar 30, 2023 $0.720 $0.785 $0.676 $0.702 2 575 810
Mar 29, 2023 $0.796 $0.796 $0.710 $0.737 2 269 933
Mar 28, 2023 $1.00 $1.02 $0.760 $0.780 4 986 891
Mar 27, 2023 $1.22 $1.27 $0.97 $1.04 4 194 275
Mar 24, 2023 $1.09 $1.22 $0.95 $1.13 3 969 569
Mar 23, 2023 $0.81 $1.23 $0.81 $1.13 8 030 912
Mar 22, 2023 $0.94 $0.96 $0.796 $0.81 4 632 402
Mar 21, 2023 $0.780 $1.02 $0.780 $1.01 5 463 390
Mar 20, 2023 $0.89 $0.90 $0.730 $0.775 1 891 959
Mar 17, 2023 $0.91 $0.95 $0.86 $0.88 1 507 021
Mar 16, 2023 $1.00 $1.01 $0.88 $0.91 2 455 081
Mar 15, 2023 $1.06 $1.12 $0.95 $1.00 4 612 667
Mar 14, 2023 $1.10 $1.39 $1.04 $1.05 7 156 606
Mar 13, 2023 $1.10 $1.14 $1.05 $1.09 1 168 985
Mar 10, 2023 $1.25 $1.26 $1.14 $1.16 1 571 025
Mar 09, 2023 $1.36 $1.40 $1.27 $1.30 1 138 988
Mar 08, 2023 $1.41 $1.49 $1.32 $1.36 1 906 844
Mar 07, 2023 $1.48 $1.49 $1.40 $1.42 912 203
Mar 06, 2023 $1.54 $1.57 $1.44 $1.45 1 093 182
Mar 03, 2023 $1.68 $1.68 $1.53 $1.57 1 335 228
Mar 02, 2023 $1.67 $1.83 $1.60 $1.67 1 763 092
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT